can semaglutide affect your liver Semaglutide might be a key for breaking the vicious cycle of metabolically associated fatty liver disease spectrum? Ozempic and GLP-1 Drugs: Risk

The decision always depends on a full review of health history rather than the symptom alone

2 Emerging evidence suggests that GLP-1 medications may be beneficial for people living with MS

#LongevityMedicine #ClinicalPractice #PreventiveMedicine #RegenerativeMedicine #HealthcareInnovation To view or add a comment, sign in A major first in obesity treatment has just been approved In a significant step forward, Rhythms therapy has become the first FDA-approved treatment for obesity linked to brain damage

Singer, W., Opfer-Gehrking, T

In April 2026 the agency removed BPC-157 from that Category 2 list, but this was a procedural step tied to withdrawn nominations and a fresh review cycle, not an approval or a finding of safety